Immediate Impact
5 by Nobel laureates 31 from Science/Nature 74 standout
Citing Papers
Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders
2024 Standout
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
2022 StandoutScience
Works of Thomas Meyer being referenced
Neurofilament light‐chain response during therapy with antisense oligonucleotide tofersen in SOD1 ‐related ALS : Treatment experience in clinical practice
2023
Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Thomas Meyer | 1793 | 1021 | 920 | 103 | 3.1k | |
| Terry Heiman‐Patterson | 1885 | 1117 | 933 | 90 | 3.4k | |
| Christian Lunetta | 2052 | 1065 | 737 | 131 | 3.1k | |
| Vincenzo La Bella | 1870 | 1124 | 919 | 110 | 3.2k | |
| Cristina Cereda | 1532 | 697 | 1905 | 172 | 4.0k | |
| Mauro Ceroni | 1504 | 557 | 1123 | 155 | 3.5k | |
| Helenius J. Schelhaas | 2798 | 1419 | 1190 | 96 | 4.4k | |
| Kathrin Meyer | 1238 | 1213 | 1688 | 85 | 3.4k | |
| Richard W. Orrell | 2155 | 1153 | 1660 | 90 | 4.0k | |
| Lorne Zinman | 2895 | 1388 | 1249 | 123 | 4.4k | |
| Uros Roessmann | 1068 | 667 | 1035 | 111 | 4.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...